Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
To investigate and engineer the weak disruptive activity of an existing therapeutic antibody, omalizumab, which targets IgE antibodies to block the allergic response.
创建时间：
2025-10-30
